{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:12:27Z","timestamp":1770185547776,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    [\n                    <jats:sup>18<\/jats:sup>\n                    F]FDG PET\/CT is widely used in the diagnosis and treatment monitoring of lung cancer, yet its ability to differentiate histologic heterogeneity remains limited. In this case, a 75-year-old man presented with a large pulmonary mass adjacent to a small satellite lesion. Bronchoscopic biopsy of the main lesion revealed small-cell lung cancer (SCLC). After first-line chemotherapy, the primary lesion showed partial response, while the smaller nodule remained stable. Posttreatment [\n                    <jats:sup>18<\/jats:sup>\n                    F]FDG and [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-DOTA-3P-TATE-RGD PET\/CT demonstrated divergent uptake patterns. Rebiopsy of the nodule with discordant tracer uptake confirmed squamous cell carcinoma, indicating synchronous double primary lung cancers. The dual-targeted tracer PET\/CT guided precise biopsy and individualized therapy.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006258","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:01:20Z","timestamp":1765904480000},"page":"244-246","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Complementary Role of [68Ga]Ga-DOTA-3P-TATE-RGD PET\/CT in Discriminating Non\u2013Small Cell From Small Cell Lung Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Jialin","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-850X","authenticated-orcid":false,"given":"Zhaohui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2025.1115","article-title":"Neoadjuvant PD-1 and PD-L1 blockade with chemotherapy for borderline resectable and unresectable stage III non\u2013small cell lung cancer","volume":"11","author":"Ricciuti","year":"2025","journal-title":"JAMA Oncol"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(23)00774-2","article-title":"First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study","volume":"402","author":"Lee","year":"2023","journal-title":"Lancet"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"JCO"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.21.01881","article-title":"Extensive-stage small-cell lung cancer: first-line and second-line treatment options","volume":"40","author":"Zugazagoitia","year":"2022","journal-title":"JCO"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"220151","DOI":"10.1183\/16000617.0151-2022","article-title":"Circulating tumour cells in patients with lung cancer universally indicate poor prognosis","volume":"31","author":"Jin","year":"2022","journal-title":"Eur Respir Rev"},{"key":"R7-20260203","first-page":"29","article-title":"A surgical case of synchronous multiple primary lung cancers with small cell carcinoma and squamous cell carcinoma","volume":"46","author":"Watanabe","year":"2021","journal-title":"Tokai J Exp Clin Med"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.7150\/thno.98819","article-title":"Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival","volume":"14","author":"Mavroeidi","year":"2024","journal-title":"Theranostics"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/RLU.0000000000004591","article-title":"Somatostatin receptor-directed PET\/CT for therapeutic decision-making and disease control in patients affected with small cell lung cancer","volume":"48","author":"Serfling","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/RLU.0000000000002680","article-title":"Evaluation of lung cancer and neuroendocrine neoplasm in a single scan by targeting both somatostatin receptor and integrin \u03b1v\u03b23","volume":"44","author":"Zheng","year":"2019","journal-title":"Clin Nucl Med"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s00259-017-3696-2","article-title":"Inter-heterogeneity and intra-heterogeneity of \u03b1v\u03b23 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging","volume":"44","author":"Kang","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"e0171301","DOI":"10.1371\/journal.pone.0171301","article-title":"68Ga-DOTATATE PET\/CT imaging of indeterminate pulmonary nodules and lung cancer. Ahn BC, ed","volume":"12","author":"Walker","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:00:35Z","timestamp":1770141635000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006258","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2025-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}